NASDAQ:AKUS - Nasdaq - US00973J1016 - Common Stock - Currency: USD
Although US stocks closed mixed on Thursday, there were a few notable insider trades.
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Akouos, Inc. (NASDAQ: AKUS). The acquisition...
Mentions: LLY
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced that the tender offer to purchase all of the issued and...
Mentions: LLY
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Akouos, Inc. ("Akouos"...
Mentions: LLY
As a pharmaceutical giant seeks to delve deeper into gene therapy, today's merger announcement has AKUS stock traders in a frenzy.
Mentions: LLY
Eli Lilly (NYSE:LLY) has announced an acquisition of Akouos (NASDAQ:AKUS) that is expected to be completed in Q4 of 2022.
Mentions: LLY
Akouos press release (AKUS): Q3 GAAP EPS of -$0.54 beats by $0.11.Cash, cash equivalents, and marketable securities were $169.3 million
-Received clearance from FDA for the AK-OTOF IND application to initiate a Phase 1/2, first in human, pediatric clinical trial -Continued progress...
A buyout agreement is lighting a fire underneath the biotech's shares today.
Mentions: LLY
Zovio (ZVO) stock is rocketing higher on Tuesday as investors prepare for an incredibly important vote next week!
/PRNewswire/ -- Ademi LLP is investigating Akouos (NASDAQ: AKUS) for possible breaches of fiduciary duty and other violations of law in its transaction with...
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced a definitive agreement for Lilly to acquire Akouos, a...
Mentions: LLY